Procavea Biotech is on a mission to transform RNA therapeutic delivery with its groundbreaking OP platform: a first-of-its-kind, nonviral protein cage designed for efficient siRNA transport. By tackling the limitations of current delivery technologies, we aspire to unlock the full potential of siRNA-based drugs, expanding their reach beyond the liver and into previously untreatable diseases. In doing so, we are not just creating new treatments - we are helping to reshape the future of precision medicine.
News
Milestones/News
